Annexon ANNX
NASDAQ ANNX
$4.24 +0.01 (+0.12%)
As of: Nov 10, 2026 · 3:58 PM EST

Annexon (ANNX) Receivables - Other (2020)

Updated

Annexon (ANNX) posted Receivables - Other of $3,000 for Q4 2020.

Analysis

Annexon (ANNX) Receivables - Other (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Annexon 857.28 Mn -4.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 3,000.00
API Access

Annexon Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANNX&period=max&api_key=YOUR_API_KEY